LakePharma is pleased to help its partners discover and produce potent and functional therapeutic antibodies with a variety of high-performance hybridoma- and display-based technologies. LakePharma's standard antibody development platform packages provide our clients with capabilities of developing robust and scaleable processes suitable for manufacturing with a short turn around time. Manufacturing of material for Toxicology and Phase I studies are performed at our cGMP manufacturing site. As the work is performed within LakePharma, we offer an efficient and seamless tech transfer process, which helps reduce the work and risk for our clients.
To learn more about the technologies used in LakePharma's antibody discovery and engineering services, click here.